Arvinas starts patient dosing of protein degrader
Arvinas has announced the initiation of patient dosing in its second clinical program. The Phase 1 clinical trial of ARV-471, an oral estrogen receptor (ER)-targeting...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
Arvinas has announced the initiation of patient dosing in its second clinical program. The Phase 1 clinical trial of ARV-471, an oral estrogen receptor (ER)-targeting...
Certain types of bacteria are capable of causing colorectal cancers, indicating that a sub-set of these cancers could be the result of infectious disease. There...
BioXcel Therapeutics reports that the U.S. DoD’s CDMRP has awarded a planning grant1 as a part of its Alcohol and Substance Abuse Disorders Research Program...
SpringWorks Therapeutics has filed to raise $115 million in an IPO. The money will take SpringWorks through to regulatory filings for two former Pfizer drugs against...
Cara Therapeutics has entered into a non-exclusive commercial license agreement with Enteris BioPharma, Inc. for oral formulation rights to Enteris’ Peptelligence® Technology. “We are pleased to...
Independent nonprofit biomedical research institute The Jackson Laboratory (JAX) has teamed with Lovelace Biomedical, Exemplar Genetics, Iontox and the University of Pennsylvania to win a...
SpringWorks Therapeutics has appointed Francis (Frank) Perier, Jr. as Chief Financial Officer (CFO). Mr. Perier previously served as the CFO of Forest Laboratories, Inc. for...
Boehringer Ingelheim and The University of Texas MD Anderson Cancer Center have announced a new multi-year partnership to conduct collaborative research to rapidly advance therapies for...
The Farmington biotech startup Rallybio reports it is working on drug discovery with Exscientia an artificial intelligence company in the United Kingdom. Steve Uden, chief...
“We continued to advance our complement factor D inhibitors in the second quarter of 2019 by efficiently executing on our global development and regulatory strategies,...